Emergent Biosolutions Inc (EBS)
Capital Expenditure
-$11.80M
TTM · Period ending: · USD
EBS Capital Expenditure
Latest reported-$11.80Mperiod ending
Latest reported-$11.80Mperiod ending
EBS TTM CapEx (-$43.97M → -$11.80M)
TTM CapEx
High-resolution chart · PNG
EBS capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -11,800,000 | |
| -12,600,000 | |
| -13,800,000 | |
| -11,600,000 | |
| -14,000,000 | |
| -15,700,000 | |
| -22,900,000 | |
| -32,600,000 | |
| -39,400,000 | |
| -47,300,000 | |
| -51,600,000 | |
| -85,600,000 | |
| -100,900,000 | |
| -120,500,000 | |
| -137,600,000 | |
| -138,900,000 | |
| -166,200,000 | |
| -201,100,000 | |
| -225,000,000 | |
| -214,300,000 | |
| -204,800,000 | |
| -172,900,000 | |
| -141,000,000 | |
| -141,100,000 | |
| -110,700,000 | |
| -89,700,000 | |
| -86,900,000 | |
| -71,625,000 | |
| -82,383,000 | |
| -81,885,000 | |
| -72,100,000 | |
| -63,722,000 | |
| -50,440,000 | |
| -46,139,000 | |
| -54,828,000 | |
| -62,395,000 | |
| -66,616,000 | |
| -78,347,000 | |
| -76,257,000 | |
| -67,424,000 | |
| -64,377,000 | |
| -53,944,000 | |
| -44,812,000 | |
| -49,683,000 | |
| -40,954,000 | |
| -35,165,000 | |
| -30,673,000 | |
| -22,222,000 | |
| -37,298,000 | |
| -38,932,000 | |
| -42,021,000 | |
| -47,322,000 | |
| -37,047,000 | |
| -39,195,000 | |
| -53,845,000 | |
| -60,816,000 | |
| -68,152,000 | |
| -67,923,000 | |
| -54,026,000 | |
| -42,212,000 | |
| -30,265,000 | |
| -25,503,000 | |
| -22,101,000 | |
| -32,953,000 | |
| -32,824,000 | |
| -33,562,000 | |
| -33,287,000 | |
| -18,725,000 | |
| -17,364,000 | |
| -18,637,000 | |
| -20,813,000 | |
| -24,236,000 | |
| -29,169,000 | |
| -34,410,000 | |
| -43,969,000 | |
| -45,092,000 |